New cancer clinical trial: Study of 6b11-OCIK Injection Treatment in Patients With Drug-resistant and Recurrence Epithelial Ovarian Cancer

Published on: May 31, 2018 at 12:00PM
Condition:   Recurrent Platinum-Resistant Ovarian Cancer
Intervention:   Biological: 6B11-OCIK injection
Sponsor:   Peking University People's Hospital
Not yet recruiting
https://ift.tt/2J5EGEx